glyburide and Leishmaniasis studies

glyburide and Leishmaniasis

glyburide has been researched along with Leishmaniasis in 2 studies

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).

Research Excerpts

Excerpt	Relevance	Reference
"Leishmaniasis is caused by a protozoan parasite, Leishmania."	5.51	Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis. ( Alaidarous, MA; Alshehri, BM; Amir, K; Arish, M; Banawas, S; Dukhyil, AAB; Kashif, M; Rub, A; Shaker, K, 2019)
"Leishmaniasis is caused by a protozoan parasite, Leishmania."	1.51	Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis. ( Alaidarous, MA; Alshehri, BM; Amir, K; Arish, M; Banawas, S; Dukhyil, AAB; Kashif, M; Rub, A; Shaker, K, 2019)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (50.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Rub, A	1
Shaker, K	1
Kashif, M	1
Arish, M	1
Dukhyil, AAB	1
Alshehri, BM	1
Alaidarous, MA	1
Banawas, S	1
Amir, K	1
Ponte-Sucre, A	1
Figarella, K	1
Moll, H	1

Studies

Rub, A

Shaker, K

Kashif, M

Arish, M

Dukhyil, AAB

Alshehri, BM

Alaidarous, MA

Banawas, S

Amir, K

Ponte-Sucre, A

Figarella, K

Moll, H

Other Studies

2 other studies available for glyburide and Leishmaniasis

Article	Year
Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis. Protein and peptide letters, 2019, Volume: 26, Issue:5 Topics: Amide Synthases; Antiprotozoal Agents; Catalytic Domain; Drug Repositioning; Glyburide; Humans; Leis	2019
Experimental leishmaniasis: the glibenclamide-triggered decrease in parasite growth correlates with changes in macrophage features. Immunopharmacology and immunotoxicology, 2001, Volume: 23, Issue:3 Topics: Animals; Antigens, CD; B7-2 Antigen; Glyburide; Histocompatibility Antigens Class II; In Vitro Techn	2001

Article

Year

Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis.

Protein and peptide letters, 2019, Volume: 26, Issue:5

Topics: Amide Synthases; Antiprotozoal Agents; Catalytic Domain; Drug Repositioning; Glyburide; Humans; Leis

2019

Experimental leishmaniasis: the glibenclamide-triggered decrease in parasite growth correlates with changes in macrophage features.

Immunopharmacology and immunotoxicology, 2001, Volume: 23, Issue:3

Topics: Animals; Antigens, CD; B7-2 Antigen; Glyburide; Histocompatibility Antigens Class II; In Vitro Techn

2001